NTRS
47
2
LH
46
8
D
38
-3
VRTX
57
4
APA
25
2
NWL
35
3
EL
24
-4
APD
37
-3
MU
51
11
CAG
50
-4
TGT
40
-3
DG
33
-9
OI
43
2
PG
61
-7
ADBE
45
10
ABBV
64
-4
CL
58
-8
DUK
74
-3
VZ
50
-2
LLY
62
3
NTRS
47
2
LH
46
8
D
38
-3
VRTX
57
4
APA
25
2
NWL
35
3
EL
24
-4
APD
37
-3
MU
51
11
CAG
50
-4
TGT
40
-3
DG
33
-9
OI
43
2
PG
61
-7
ADBE
45
10
ABBV
64
-4
CL
58
-8
DUK
74
-3
VZ
50
-2
LLY
62
3
Financhill
Back

Fifth Third Bancorp Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
43

FITB
Fifth Third Bancorp

Last Price:
$38.16
Seasonality Move:
8.66%
Buy
55

SRPT
Sarepta Therapeutics

Last Price:
$98.36
Seasonality Move:
6.73%
Sell
43
Fifth Third Bancorp (FITB) is a Sell

Is Fifth Third Bancorp a Buy, Sell or Hold?

  • The current Fifth Third Bancorp [FITB] share price is $38.53. The Score for FITB is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • FITB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $99.77. The Score for SRPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

FITB Stock Price Chart

What is Fifth Third Bancorp's stock price today?

  • The Fifth Third Bancorp share price today is $38.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FITB is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $99.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

FITB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.22 Sell
Relative Strength Index (14 RSI): 25.65 Sell
Chaikin Money Flow: 881982 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (40.92 - 44.48) Sell
Bollinger Bands (100): (42.21 - 46.33) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.4 Sell
Relative Strength Index (14 RSI): 37.2 Sell
Chaikin Money Flow: -420668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (103.16 - 112.22) Sell
Bollinger Bands (100): (109.63 - 127.19) Sell

FITB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.66 Sell
20-day SMA: 42.39 Sell
50-day SMA: 43.03 Sell
200-day SMA: 41.93 Sell
8-day EMA: 40.23 Sell
20-day EMA: 41.76 Sell
50-day EMA: 42.94 Sell
200-day EMA: 41.6 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 103.49 Sell
20-day SMA: 106.07 Sell
50-day SMA: 113.88 Sell
200-day SMA: 126.52 Sell
8-day EMA: 103.1 Sell
20-day EMA: 106.21 Sell
50-day EMA: 111.8 Sell
200-day EMA: 120.79 Sell

Fifth Third Bancorp Earnings Growth & FITB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.08 per share, an increase this year of $0.32 per share, and an increase next year of $0.46 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.65 per share, and an increase next year of $5.25 per share.

Fifth Third Bancorp Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):